美年健康收盘下跌1.51%，滚动市盈率69.61倍，总市值204.32亿元

Core Viewpoint - The company Meinian Health has a current stock price of 5.22 yuan, with a rolling PE ratio of 69.61 times, significantly higher than the industry average of 38.04 times, indicating potential overvaluation in the market [1] Group 1: Company Performance - For Q1 2025, Meinian Health reported a revenue of 1.754 billion yuan, a year-on-year decrease of 2.62% [1] - The net profit for the same period was -275.34 million yuan, reflecting a year-on-year increase of 3.94% in losses [1] - The company's gross profit margin stands at 24.04% [1] Group 2: Market Position - Meinian Health's total market capitalization is 20.432 billion yuan [1] - In terms of PE ratio, the company ranks 35th within the healthcare services industry, which has an average PE of 38.04 times and a median PE of 42.05 times [2] - The main business of Meinian Health is health examination services, with the primary product being examination services [1] Group 3: Capital Flow - On May 28, 2023, there was a net outflow of 5.9211 million yuan in principal funds for Meinian Health, although the overall trend over the past five days showed a net inflow of 124 million yuan [1]